Griffith University

Therapeutic Innovation Australia – The Pipeline Accelerator 2021-22 (Round 2) applications now open

February 22nd, 2022

Therapeutic Innovation Australia (TIA), supports and facilitates researcher and SME access to a diverse range of Australian translational medical research capabilities. One specific mechanism, providing rapid, entry-level access is via a voucher-style scheme Рthe Pipeline Accelerator.

The Pipeline Accelerator 2021-22 provides SMEs and researchers access to one or more facilities associated with TIA, including core facilities like Griffith Discovery Biology.

Discovery Biology provides the following services eligible for the TIA scheme: Small molecule high throughput screening and assay development. Please contact us to discuss options for your project further.

Five levels of funding are offered: Increments starting from $10,000 ex GST to a maximum of $50,000 ex GST;i.e., $10,000/$20,000/$30,000/$40,000 or $50,000 ex GST.

Please note co-investment (cash only) is needed (50:50), existing funding sources can be leveraged

For more information on the TIA Voucher scheme please visit:

Submit your application latest by Friday 29 April 2022, 5pm AEST